These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 17189404

  • 1. Aberrant promoter methylation profile and association with survival in patients with non-small cell lung cancer.
    Gu J, Berman D, Lu C, Wistuba II, Roth JA, Frazier M, Spitz MR, Wu X.
    Clin Cancer Res; 2006 Dec 15; 12(24):7329-38. PubMed ID: 17189404
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of p16(INK4a) hypermethylation in non-small cell lung cancer is evident by quantitative DNA methylation analysis.
    Ota N, Kawakami K, Okuda T, Takehara A, Hiranuma C, Oyama K, Ota Y, Oda M, Watanabe G.
    Anticancer Res; 2006 Dec 15; 26(5B):3729-32. PubMed ID: 17094392
    [Abstract] [Full Text] [Related]

  • 3. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.
    Yanagawa N, Tamura G, Oizumi H, Kanauchi N, Endoh M, Sadahiro M, Motoyama T.
    Lung Cancer; 2007 Oct 15; 58(1):131-8. PubMed ID: 17606310
    [Abstract] [Full Text] [Related]

  • 4. Hypermethylation of RASSF1A promoter is associated with the age at starting smoking and a poor prognosis in primary non-small cell lung cancer.
    Kim DH, Kim JS, Ji YI, Shim YM, Kim H, Han J, Park J.
    Cancer Res; 2003 Jul 01; 63(13):3743-6. PubMed ID: 12839968
    [Abstract] [Full Text] [Related]

  • 5. Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung.
    Kim JS, Kim H, Shim YM, Han J, Park J, Kim DH.
    Carcinogenesis; 2004 Nov 01; 25(11):2165-71. PubMed ID: 15231689
    [Abstract] [Full Text] [Related]

  • 6. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.
    Nakata S, Sugio K, Uramoto H, Oyama T, Hanagiri T, Morita M, Yasumoto K.
    Cancer; 2006 May 15; 106(10):2190-9. PubMed ID: 16598757
    [Abstract] [Full Text] [Related]

  • 7. Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival.
    Brabender J, Usadel H, Danenberg KD, Metzger R, Schneider PM, Lord RV, Wickramasinghe K, Lum CE, Park J, Salonga D, Singer J, Sidransky D, Hölscher AH, Meltzer SJ, Danenberg PV.
    Oncogene; 2001 Jun 14; 20(27):3528-32. PubMed ID: 11429699
    [Abstract] [Full Text] [Related]

  • 8. Hypermethylation of p16(INK4a) and p15(INK4b) genes in non-small cell lung cancer.
    Kurakawa E, Shimamoto T, Utsumi K, Hirano T, Kato H, Ohyashiki K.
    Int J Oncol; 2001 Aug 14; 19(2):277-81. PubMed ID: 11445839
    [Abstract] [Full Text] [Related]

  • 9. Correlation between insulin-like growth factor-binding protein-3 promoter methylation and prognosis of patients with stage I non-small cell lung cancer.
    Chang YS, Wang L, Liu D, Mao L, Hong WK, Khuri FR, Lee HY.
    Clin Cancer Res; 2002 Dec 14; 8(12):3669-75. PubMed ID: 12473575
    [Abstract] [Full Text] [Related]

  • 10. Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer.
    Kim H, Kwon YM, Kim JS, Lee H, Park JH, Shim YM, Han J, Park J, Kim DH.
    J Clin Oncol; 2004 Jun 15; 22(12):2363-70. PubMed ID: 15197197
    [Abstract] [Full Text] [Related]

  • 11. Cohypermethylation of p16 and FHIT promoters as a prognostic factor of recurrence in surgically resected stage I non-small cell lung cancer.
    Kim JS, Kim JW, Han J, Shim YM, Park J, Kim DH.
    Cancer Res; 2006 Apr 15; 66(8):4049-54. PubMed ID: 16618724
    [Abstract] [Full Text] [Related]

  • 12. p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer.
    Bearzatto A, Conte D, Frattini M, Zaffaroni N, Andriani F, Balestra D, Tavecchio L, Daidone MG, Sozzi G.
    Clin Cancer Res; 2002 Dec 15; 8(12):3782-7. PubMed ID: 12473590
    [Abstract] [Full Text] [Related]

  • 13. Quantitative O(6)-methylguanine DNA methyltransferase methylation analysis in curatively resected non-small cell lung cancer: associations with clinical outcome.
    Brabender J, Usadel H, Metzger R, Schneider PM, Park J, Salonga D, Tsao-Wei DD, Groshen S, Lord RV, Takebe N, Schneider S, Hölscher AH, Danenberg KD, Danenberg PV.
    Clin Cancer Res; 2003 Jan 15; 9(1):223-7. PubMed ID: 12538473
    [Abstract] [Full Text] [Related]

  • 14. Hypermethylation of E-cadherin gene is frequent and independent of p16INK4A methylation in non-small cell lung cancer: potential prognostic implication.
    Shimamoto T, Ohyashiki JH, Hirano T, Kato H, Ohyashiki K.
    Oncol Rep; 2004 Aug 15; 12(2):389-95. PubMed ID: 15254707
    [Abstract] [Full Text] [Related]

  • 15. Hypermethylation of the TSLC1/IGSF4 promoter is associated with tobacco smoking and a poor prognosis in primary nonsmall cell lung carcinoma.
    Kikuchi S, Yamada D, Fukami T, Maruyama T, Ito A, Asamura H, Matsuno Y, Onizuka M, Murakami Y.
    Cancer; 2006 Apr 15; 106(8):1751-8. PubMed ID: 16534787
    [Abstract] [Full Text] [Related]

  • 16. Promoter methylation of retinoic acid receptor beta 2 and the development of second primary lung cancers in non-small-cell lung cancer.
    Kim JS, Lee H, Kim H, Shim YM, Han J, Park J, Kim DH.
    J Clin Oncol; 2004 Sep 01; 22(17):3443-50. PubMed ID: 15277540
    [Abstract] [Full Text] [Related]

  • 17. Expression of telomere-associated genes as prognostic markers for overall survival in patients with non-small cell lung cancer.
    Lin X, Gu J, Lu C, Spitz MR, Wu X.
    Clin Cancer Res; 2006 Oct 01; 12(19):5720-5. PubMed ID: 17020976
    [Abstract] [Full Text] [Related]

  • 18. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients.
    Esteller M, Sanchez-Cespedes M, Rosell R, Sidransky D, Baylin SB, Herman JG.
    Cancer Res; 1999 Jan 01; 59(1):67-70. PubMed ID: 9892187
    [Abstract] [Full Text] [Related]

  • 19. Promoter hypermethylation of resected bronchial margins: a field defect of changes?
    Guo M, House MG, Hooker C, Han Y, Heath E, Gabrielson E, Yang SC, Baylin SB, Herman JG, Brock MV.
    Clin Cancer Res; 2004 Aug 01; 10(15):5131-6. PubMed ID: 15297416
    [Abstract] [Full Text] [Related]

  • 20. Hypermethylation of FHIT as a prognostic marker in nonsmall cell lung carcinoma.
    Maruyama R, Sugio K, Yoshino I, Maehara Y, Gazdar AF.
    Cancer; 2004 Apr 01; 100(7):1472-7. PubMed ID: 15042681
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.